Harvard Bioscience (HBIO) Gross Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported Gross Margin of 58.99% for Q1 2026, up 304.0% year-over-year from 14.6% in Q1 2025, and down 1.2% on a QoQ basis from 59.71% in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of Gross Margin data on file, last reported at 58.99% in Q1 2026.
- Quarterly Gross Margin rose 304.0% year-over-year to 58.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 58.42% (up 133.0% YoY) and the FY2025 annual result came in at 57.67%, down 51.0% from the prior year.
- Gross Margin slipped to 58.99% in Q1 2026 per HBIO's latest filing, from 59.71% in the prior quarter.
- Across five years, Gross Margin topped out at 61.2% in Q1 2023 and bottomed at 45.21% in Q3 2022.
- The 5-year median for Gross Margin is 57.97% (2023), against an average of 57.14%.
- The widest annual swing landed in 2022, when Gross Margin sank 977 bps; it then jumped 1285 bps in 2023.
- Tracing HBIO's Gross Margin over 5 years: stood at 55.7% in 2022, then increased by 4 bps to 57.99% in 2023, then decreased by 2 bps to 57.06% in 2024, then climbed by 5 bps to 59.71% in 2025, then decreased by 1 bps to 58.99% in 2026.
- Per Business Quant, the three latest HBIO Gross Margin figures stand at 58.99% (Q1 2026), 59.71% (Q4 2025), and 58.38% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 66.06% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 45.69% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 62.25% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 35.08% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 54.66% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 67.88% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 70.82% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 32.99% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 35.80% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | 58.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.99% |
| Dec 31, 2025 | 59.71% |
| Sep 30, 2025 | 58.38% |
| Jun 30, 2025 | 56.40% |
| Mar 31, 2025 | 55.96% |
| Dec 31, 2024 | 57.06% |
| Sep 30, 2024 | 58.10% |
| Jun 30, 2024 | 57.23% |
| Mar 31, 2024 | 60.26% |
| Dec 31, 2023 | 57.99% |
| Sep 30, 2023 | 58.06% |
| Jun 30, 2023 | 57.97% |
| Mar 31, 2023 | 61.20% |
| Dec 31, 2022 | 55.70% |
| Sep 30, 2022 | 45.21% |
| Jun 30, 2022 | 56.96% |
| Mar 31, 2022 | 56.21% |
| Dec 31, 2021 | 59.17% |
| Sep 30, 2021 | 54.98% |
| Jun 30, 2021 | 56.01% |
| Mar 31, 2021 | 57.18% |
| Dec 31, 2020 | 57.15% |
| Sep 30, 2020 | 56.14% |
| Jun 30, 2020 | 59.45% |
| Mar 31, 2020 | 54.61% |
| Dec 31, 2019 | 55.64% |
| Sep 30, 2019 | 54.63% |
| Jun 30, 2019 | 53.93% |
| Mar 31, 2019 | 57.28% |
| Dec 31, 2018 | 55.35% |
| Sep 30, 2018 | 55.24% |
| Jun 30, 2018 | 48.71% |
| Mar 31, 2018 | 49.59% |
| Dec 31, 2017 | 50.91% |
| Sep 30, 2017 | 50.76% |
| Jun 30, 2017 | 47.86% |
| Mar 31, 2017 | 52.95% |
| Dec 31, 2016 | 45.83% |
| Sep 30, 2016 | 46.75% |
| Jun 30, 2016 | 44.67% |
| Mar 31, 2016 | 48.01% |
| Dec 31, 2015 | 45.56% |
| Sep 30, 2015 | 45.57% |
| Jun 30, 2015 | 43.73% |
| Mar 31, 2015 | 44.55% |
| Dec 31, 2014 | 45.66% |
| Sep 30, 2014 | 44.96% |
| Jun 30, 2014 | 45.54% |
| Mar 31, 2014 | 45.42% |
| Dec 31, 2013 | 43.25% |
| Sep 30, 2013 | 44.95% |
| Jun 30, 2013 | 46.33% |
| Mar 31, 2013 | 47.00% |
| Dec 31, 2012 | 47.41% |
| Sep 30, 2012 | 45.85% |
| Jun 30, 2012 | 47.71% |
| Mar 31, 2012 | 47.25% |
| Dec 31, 2011 | 45.57% |
| Sep 30, 2011 | 45.02% |
| Jun 30, 2011 | 47.10% |
| Mar 31, 2011 | 47.01% |
| Dec 31, 2010 | 48.81% |
| Sep 30, 2010 | 47.51% |
| Jun 30, 2010 | 46.52% |